Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure

Pan-β-Lactam Resistance Development in Pseudomonas aeruginosa Clinical Strains: Molecular Mechanisms, Penicillin-Binding Protein Profiles, and Binding Affinities

(2012) Bartolomé Moyá et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First Report of a Pseudomonas aeruginosa Isolate Coharboring KPC and VIM Carbapenemases

(2012) A. Correa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First report of a Pseudomonas aeruginosa clinical isolate co-harbouring KPC-2 and IMP-18 carbapenemases

(2012) Teresa Martínez et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comparative Evaluation of Tigecycline Susceptibility Testing Methods for Expanded-Spectrum Cephalosporin- and Carbapenem-Resistant Gram-Negative Pathogens

(2012) O. Zarkotou et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The Challenges of Antimicrobial Drug Resistance in Greece

(2011) S. Miyakis et al.   CLINICAL INFECTIOUS DISEASES

Pseudomonas Aeruginosa: Resistance to the Max

(2011) Keith Poole   Frontiers in Microbiology

Emerging Klebsiella pneumoniae Isolates Coproducing KPC-2 and VIM-1 Carbapenemases

(2009) P. Giakkoupi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa

(2009) J.-M. Rodriguez-Martinez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem

(2008) Anna Farra et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS